To evaluate the inhibitory effect of GaAD19 on tumor growth of U14 cervical cancer mice, we established a subcutaneous cervical cancer xenograft model and treated nude mice with different doses of GaAD19, CTX, or medium dose GaAD19 combined with a JNK agonist (Fig. 8A). This evidence concerns the gene MAPK8 and cervical cancer.